Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Teleo, Standard Videoconferencing.
- Who it may be relevant to
- Registry conditions: Anxiety, Mood Disorders. Basic parameters: 5 years — 14 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
Detailed description
This study aims to examine the impact of tailored telehealth psychotherapy environments on clinical outcomes in the context of pediatric mental health treatment. Researchers will conduct a full-scale RCT with 156 families to assess how Teleo compares to standard video conferencing (e.g., Zoom) on a range of clinical metrics, including cancellation/no-show rates, clinician satisfaction, duration of treatment, need for medication, and symptoms of anxiety and depression.
Interventions
- Other Teleo
Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform. - Other Standard Videoconferencing
Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform.
Primary outcome measures
- Child Involvement Rating Scale (CIRS) [Time frame: Week 1]
Secondary outcome measures (6)
- My Thoughts About Therapy Scale - Caregiver (MTT-CG) [Time frame: Weeks 1, 6 and 12]
- My Thoughts About Therapy Scale - Youth (MTT-Y) [Time frame: Weeks 1, 6 and 12]
- Revised Children's Anxiety and Depression Scale (RCADS) [Time frame: Baseline, Week 4, Week 12]
- Rate of therapy session cancellations, no-shows, and treatment dropout [Time frame: Weeks 1-12]
- Rate of clinician attrition [Time frame: Weeks 1-12]
- Long-Term Cost of Care [Time frame: 1 year post-enrollment]
Eligibility criteria
Inclusion criteria
- Diagnosed with a mood and/or anxiety disorder
- Have proficiency to participate in psychotherapy in English
- Scheduled to begin therapy at one of the study sites
- RCADS score > 65
Exclusion criteria
\- Comorbid diagnosis of intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidal behaviors requiring immediate hospitalization, substance use disorders, or other physical or mental condition that would prohibit them from engaging in telehealth settings.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
United States · 2 centers
- Ohana Center for Child and Adolescent Behavioral Health — Monterey
- Stanford University — Stanford
Identifiers
NCT: NCT07155707 · 80119 · R42MH136878